HomeBotulinum Toxin Type ABotulinum Toxin Type A + Onabotulinumtoxina

Does Botulinum Toxin Type A Interact with Onabotulinumtoxina?

Botulinum Toxin Type A and Onabotulinumtoxina have a major drug interaction according to U.S. FDA drug labeling data. Administration at the same time or within several months may cause excessive neuromuscular weakness. Effect is unknown and weakness may be exacerbated. The mechanism involves additive neuromuscular blocking effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Botulinum Toxin Type A Class
Acetylcholine Release Inhibitor
Onabotulinumtoxina Class
Acetylcholine Release Inhibitor
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Botulinum Toxin Type A and Onabotulinumtoxina occurs because additive neuromuscular blocking effects. Clinically, this means administration at the same time or within several months may cause excessive neuromuscular weakness. effect is unknown and weakness may be exacerbated. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Botulinum Toxin Type A and your doctor is considering prescribing Onabotulinumtoxina (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Botulinum Toxin Type A(Dysport)+💊 Onabotulinumtoxina(Botox)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Acetylcholine Release Inhibitor
Drug B class
Acetylcholine Release Inhibitor
Source
NLP:onabotulinumtoxina

What this means in plain English

Administration at the same time or within several months may cause excessive neuromuscular weakness. Effect is unknown and weakness may be exacerbated.

What the FDA label says

"Additive neuromuscular blocking effects"

📖 Source: NLP:onabotulinumtoxina

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Botulinum Toxin Type A and Onabotulinumtoxina against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.